The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

– Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative technology via ...

New research from Johns Hopkins Medicine suggests that low blood sugar may contribute to diabetic retinopathy and vision loss. The study identifies how hypoglycemia triggers damaging effects in ...

IgA Nephropathy: Pathogenesis and the 4-Hit Cascade IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium.

Hammes, H.-P. (2005) Pericytes and the Pathogenesis of Diabetic Retinopathy. Hormone and Metabolic Research, 37, 39-43.

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes, according to a retrospective analysis.

Diabetic retinopathy is the main microvascular complication of diabetes and the first blinding eye disease in the working-age population. Oxidative stress is an important pathogenesis of diabetic ...

A fundus photo is a picture of the back of the eye that can show changes in diabetic retinopathy. Read about the signs of disease and how selfie images work.

Valo's ROCK 1 and 2 inhibitor failed to reduce the severity of diabetic retinopathy, leading the Flagship-founded biotech to drop the candidate.

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based ...